Implantable Cardiac Monitor Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User [Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)] - Global Opportunity Analysis and Industry Forecast, 2020-2030
Industry: Healthcare | Publish Date: 28-Nov-2024 | No of Pages: 228 | No. of Tables: 125 | No. of Figures: 105 | Format: PDF | Report Code : HC44
Market Definition
The Global Implantable Cardiac Monitor Market was valued at USD 521.41 million in 2019 and is predicted to reach USD 1 billion by 2030 with a CAGR of 6.1% from 2020-2030.
The implantable cardiac monitor is also known as the implantable loop recorder. These are small devices that can be inserted into the human body for continuously monitoring their heart beats. They have the ability to not only monitor but also to evaluate and report the inconsistent and unexplained arrhythmias. The increasing prevalence of cardiac arrhythmias such as atrial fibrillation and bradycardia has boosted the demand for implantable cardiac monitor market globally.
Market Dynamics and Trends
The implantable cardiac monitor eliminates the need for bulky external monitors that require inconvenient wire leads attached to the patient. Technological advancements in cardiac monitor devices have made them easier to be implanted under the skin of the patient’s chest for continuously monitoring their heart and detect cardiac arrhythmias and atrial fibrillation.
Increasing incidences of atrial fibrillation, myocardial infarction, and arrhythmias have been driving the growth of global implantable cardiac monitor market. Also, factors such as durability of implantable cardiac monitors along with other advantages they offer such as reduced duration of hospitalization and lesser readmission requirements are contributing to the growth of this market.
Moreover, investments made by the key players in the R&D to innovate such devices are also supporting the growth of implantable cardiac monitor market. However, the availability of alternative modes of treatments and high cost associated with implantable monitors are hampering the growth of this market to some extent. On the other hand, increased awareness about the advantages of these devices is expected to create new opportunities for market players in the coming future.
Market Segmentations and Scope of the Study:
The implantable cardiac monitor market is segmented into indication, end user and geography. On the basis of indication, the market is segmented into cardiac arrhythmias, atrial fibrillation, epilepsy and unexplained falls. On the basis of end user, the market is segmented into hospitals, cardiac centers & clinics, and ambulatory surgery centers. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.
Geographical Analysis:
The North American region is anticipated to hold the lion share of the market during the forecast period. This is attributable to the factors including high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework.
However, Asia Pacific region is expected to show rapid and consistent growth in terms of market share within the forecast period owing to factors such as increasing prevalence of atrial fibrillation, rise in obesity, and growing geriatric population.
Competitive Landscape:
Lucrative growth opportunities make the implantable cardiac monitor market extremely competitive. Some of the major players in the market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by the market players to maintain market dominance.
Key Benefits:
-
The implantable cardiac monitor report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on
-
The study comprises a deep dive analysis of the implantable cardiac monitor market trend including the current and future trends for depicting the prevalent investment pockets in the market
-
The information related to key drivers, restraints and opportunities and their impact on the implantable cardiac monitor market is provided in the report.
-
The market share of the players in the global implantable cardiac monitor market along with their competitive analysis.
-
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
Key Market Segments:
By Indication
-
Cardiac Arrhythmias
-
Atrial Fibrillation
-
Epilepsy & Unexplained Falls
By End User
-
Hospitals
-
Cardiac Centers & Clinics
-
Ambulatory Surgical Centers
By Geography
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Switzerland
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
China
-
India
-
Australia
-
Malaysia
-
New Zealand
-
Rest of Asia-Pacific
-
-
RoW
-
Brazil
-
South Africa
-
Egypt
-
Remaining Countries
-
Key Players:
-
Abbott Laboratories
-
Biotronik SE & Co. KG
-
Boston Scientific Corporation
-
Edwards Lifescience Corporation
-
General Electric Company
-
Koninklijke Philips N.V.
-
LivaNova PLC
-
Medtronic plc
-
Nihon Kohden Corporation
-
Phoenix Heart Center
REPORT SCOPE AND SEGMENTATION:
|
Parameters |
Details |
|
Analysis Period |
2019–2030 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2020–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Market Segmentation |
By Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained Falls) By End User (Hospitals, Cardiac Centers & Clinics, Ambulatory Surgical Centers (ASCs) |
|
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Spain, Switzerland, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Malaysia, New Zealand, Rest of APAC), Rest of the World (Brazil, South Africa, Egypt, Remaining Countries) |
|
Companies Profiled |
Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center |
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Qualitative Approach
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
Our Specialized Toolbox for Industry-Specific Market Research
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
Information Procurement
The stage entails acquiring market data or relevant information through various sources and methodologies.
Market Research Approach
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
Porters Five Forces Analysis
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
SWOT Analysis
We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.
Forecasting
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
Frequently Asked Questions
Download Free Sample
Speak to Our Analyst
Related Report
Related Blogs
Role Of Companies In Shaping The Blood Gas And Electrolyte Analyzer Market
According to Next Move Strategy Consulting, the global blood...
Analysis of Key Players Operating in the Global Surgical Instrument Industry
Next Move Strategy Consulting forecasts more than 1.7-fold g...
CBCT Industry Is Dominated By Dentsply Sirona, Philips, & Vatech With More Than 45% – Know Why
Next Move Strategy Consulting predicts a significant growth...
